Home      Patients      Professionals      About WCG      Services      Technology      Contact Us  

Did you know that many potentially effective drugs exist in nearly every cancer type?  However, a chemotherapy drug treatment that helps one patient often does not help another patient with same type of cancer.  So how can you be sure the chemotherapy treatment prescribed for you is the one that has the best chance of fighting your cancer?  

Weisenthal Cancer Group provides an accurate treatment selection method called Personalized  Cytometric Cancer Profiling.  Your own living cancer cells are tested in the laboratory before you receive treatment.  You learn exactly which chemotherapy drugs and drug combinations are most effective at killing your cancer cells and which agents are not effective.  Personalized cytometric profiling pinpoints the most promising chemotherapy regimen for you and you alone and spares you needless exposure to ineffective drugs.  It includes the newest molecularly targeted, immunologic, and anti-vascular agents.  



“I have had patients who came from the most prestigious cancer centers in America on hospice care who had their disease eradicated by using the drugs suggested by Dr. Weisenthal’s chemosensitivity and chemoresistance testing.  The value of this testing is acute in the initial and subsequent management of many cancers.”

William R. Grace, M.D.

Grace Oncology

New York, NY




“An integrative approach to cancer management includes using laboratory tools that make it possible to tailor treatments precisely.  Dr. Weisenthal’s cytometric profiling testing enables me to design the best personalized therapy targeted for each patient.“

Mark Rosenberg, M.D.

Rosenberg Integrative Cancer Treatment and Research Institute

Boca Raton, FL

“In my perfect world, every person with cancer who is a candidate for chemotherapy, biologic targeted agents, or immunotherapy would receive cytometric profiling first.  Period.  Because it’s so clinically reliable, and far better than any other technology available when it comes to predicting therapeutic response.  I have consistently been greatly impressed by the results patients get when their therapy is guided by your profiling, even in heavily pre-treated, refractory settings."

Marc C. Bricca, ND, LAc

Bodhicitta Healing Arts

Sebastopol, CA 95472

“I just wanted to let you know that the chemo regimen you recommended was EXTREMELY effective with me.”

Ovarian Cancer Patient

"We cannot thank you enough.  First of all, for the passion you have for your work and the life you breathe back into cancer victims.  You are such a blessing.  Thank you from all of our little group for...your kindness, and your treasured knowledge.”

Pancreatic Cancer Patient

“You performed an assay on my cancer 2.5 years ago. I'm healthy today and I did the treatment recommended by the assay…your assay predicted [effectiveness of a new drug combination] a few years before the clinical research was in place!”

Breast Cancer Patient

Have you heard about gene testing?   It is another approach to personalized medicine but very different from what we do and not nearly as effective.  Read what NPR (National Public Radio) reported on the topic.  

Excerpt:  "At Hopkins, the genomic tests usually don't offer any suggestion for treatment. Only about one quarter of patients at Hopkins are steered toward particular drugs or toward ongoing clinical trials. Other top medical centers find they can identify potential treatments only about 10 percent of the time.

So far there's only been one randomized study of this approach to precision cancer care — and it did not show a survival advantage for people who went through all this genetic testing."

Read the full article here